| scholarly article | Q13442814 |
| P50 | author | Paul P Van Veldhoven | Q96050228 |
| Gerhard Liebisch | Q42705098 | ||
| Eveline Baumgart-Vogt | Q47158610 | ||
| Srikanth Karnati | Q52894062 | ||
| Vannuruswamy Garikapati | Q59674206 | ||
| P2093 | author name string | Gerd Schmitz | |
| Bernhard Spengler | |||
| P2860 | cites work | A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 |
| Effect of pulmonary surfactant protein B (SP-B) and calcium on phospholipid adsorption and squeeze-out of phosphatidylglycerol from binary phospholipid monolayers containing dipalmitoylphosphatidylcholine | Q28265158 | ||
| Principles of bioactive lipid signalling: lessons from sphingolipids | Q28265743 | ||
| A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice | Q28505262 | ||
| Sphingomyelin metabolism is developmentally regulated in rat lung | Q28577486 | ||
| Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures | Q28609597 | ||
| Lipidomics reveals dramatic lipid compositional changes in the maturing postnatal lung | Q28817762 | ||
| Leukotrienes and lipoxins: structures, biosynthesis, and biological effects | Q29617543 | ||
| Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus | Q31134484 | ||
| Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study | Q33389830 | ||
| Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection | Q33591425 | ||
| Pulmonary surfactant in health and human lung diseases: state of the art. | Q33710309 | ||
| MALDI imaging MS of phospholipids in the mouse lung | Q33878265 | ||
| Postnatal growth of the mouse lung | Q34044725 | ||
| The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies | Q34258879 | ||
| Functions of plasmalogen lipids in health and disease | Q34277117 | ||
| The role of lipids in pulmonary surfactant. | Q34479899 | ||
| Surfactant lipidomics in healthy children and childhood interstitial lung disease | Q35098582 | ||
| Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation | Q35143143 | ||
| The surfactant system of the adult lung: physiology and clinical perspectives | Q35364694 | ||
| Functions and biosynthesis of plasmalogens in health and disease. | Q35784922 | ||
| Postnatal development of the bronchiolar club cells of distal airways in the mouse lung: stereological and molecular biological studies | Q35900374 | ||
| Phosphatidylglycerol suppresses influenza A virus infection | Q35987319 | ||
| Surfactant phospholipids: synthesis and storage | Q36019217 | ||
| Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry | Q36040256 | ||
| The role of surfactant in respiratory distress syndrome | Q36131235 | ||
| Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often | Q73841511 | ||
| Pulmonary surfactant in birds: coping with surface tension in a tubular lung | Q74015000 | ||
| Peroxisomes in mouse and human lung: their involvement in pulmonary lipid metabolism | Q81716149 | ||
| The effect of growth on the lipid composition of rat tissues | Q82073994 | ||
| Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics | Q36558343 | ||
| Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant. | Q36837803 | ||
| Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol | Q36986386 | ||
| An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease | Q37418480 | ||
| Old and new generation lipid mediators in acute inflammation and resolution | Q37775277 | ||
| Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases | Q37888849 | ||
| Chain length-specific properties of ceramides | Q37963643 | ||
| Lung surfactant DPPG phospholipid inhibits vaccinia virus infection. | Q39629041 | ||
| Shorthand notation for lipid structures derived from mass spectrometry. | Q40470345 | ||
| Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity | Q40941153 | ||
| Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism | Q41270282 | ||
| Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects | Q41851858 | ||
| The postnatal growth of the rat lung. I. Morphometry | Q43589639 | ||
| A comparison of the molecular species compositions of mammalian lung surfactant phospholipids | Q43615293 | ||
| Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development | Q43810947 | ||
| Increasing plasmalogen levels protects human endothelial cells during hypoxia | Q44068495 | ||
| Modifications of surfactant phospholipid pattern in premature infants treated with curosurf: clinical and dietary correlations | Q44217069 | ||
| High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. | Q44225943 | ||
| The identification of phosphatidylglycerol in the rat, rabbit, monkey and human lung | Q44779666 | ||
| Sphingolipids in the lungs. | Q44965785 | ||
| The cerebro-hepato-renal (Zellweger) syndrome. Impaired de novo biosynthesis of plasmalogens in cultured skin fibroblasts | Q44971908 | ||
| Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids | Q45090709 | ||
| Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis | Q45091543 | ||
| Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity | Q45121987 | ||
| High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm | Q45136777 | ||
| Altered surfactant function and metabolism in rabbits with acute lung injury | Q46125452 | ||
| Dipalmitoylphosphatidylcholine is not the major surfactant phospholipid species in all mammals. | Q46612946 | ||
| High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
| Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure | Q47202761 | ||
| Surfactant palmitoylmyristoylphosphatidylcholine is a marker for alveolar size during disease | Q47382631 | ||
| Lipid synthesis in various organs of the rat during postnatal development. | Q48395918 | ||
| Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages. | Q50708380 | ||
| Surfactant in newborn compared with adolescent pigs: adaptation to neonatal respiration. | Q51647084 | ||
| Surfactant replacement therapy for preterm and term neonates with respiratory distress. | Q51762422 | ||
| Developmental changes in rat surfactant lipidomics in the context of species variability. | Q51979868 | ||
| Phosphatidylglycerol in rat lung. I. Identification as a metabolically active phospholipid in isolated perfused rat lung | Q54302882 | ||
| The phospholipid composition of pig lung surfactant. | Q54657330 | ||
| Increased palmitoyl-myristoyl-phosphatidylcholine in neonatal rat surfactant is lung specific and correlates with oral myristic acid supply | Q56638879 | ||
| Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema | Q60364456 | ||
| Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS) | Q61863054 | ||
| Surface respreading after collapse of monolayers containing major lipids of pulmonary surfactant | Q68045862 | ||
| Phosphatidylinositol and not phosphatidylglycerol is the important minor phospholipid in rhesus-monkey surfactant | Q68983890 | ||
| The postnatal development and growth of the human lung. II. Morphology | Q69003353 | ||
| Decreased phosphatidyl choline content in bronchoalveolar lavage fluids of children with bronchopulmonary dysplasia: a preliminary investigation | Q69035846 | ||
| Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant | Q69801966 | ||
| Lipid composition of alveolar macrophage plasma membrane during postnatal development | Q70118965 | ||
| Beagle dog pulmonary surfactant lipids. Lipid composition of pulmonary tissue, exfoliated lining cells and surfactant | Q70573844 | ||
| Changes in phospholipid composition of lung surfactant during development in the fetal lamb | Q71245828 | ||
| Bovine pulmonary surfactant: chemical composition and physical properties | Q71246521 | ||
| Pulmonary Surfactant and Evolution of the Lungs | Q71454162 | ||
| Amniotic fluid phosphatidylglycerol: an early indicator of fetal lung maturity | Q71660050 | ||
| Surface properties of binary mixtures of some pulmonary surfactant components | Q71847557 | ||
| Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin | Q73512587 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0203464 | |
| P577 | publication date | 2018-09-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry | |
| P478 | volume | 13 |
| Q64092469 | High-resolution atmospheric-pressure MALDI mass spectrometry imaging workflow for lipidomic analysis of late fetal mouse lungs | cites work | P2860 |
Search more.